KOLOA, Hawaii — The ocular surface should not be forgotten when managing patients with glaucoma, according to a presenter at Hawaiian Eye 2020.
“Glaucoma management causes dry eye and ocular surface disease,” Preeya K. Gupta, MD, said.
Evidence shows that ocular surface disease is present in up to 59% of patients with glaucoma using drops, according to Gupta.
“That means it is more likely that the patient in your chair will have coincident ocular surface disease than not,” she said.
Topical medications for glaucoma can be toxic and inflammatory, and surgery can
Uncategorized